Multidisciplinary team evaluates antithrombotic therapy for older patients with atrial fibrillation
Impact of Multidisciplinary Team Approach on the Utilization and Risks Related to Antithrombotic Drugs in Older Patients With Atrial Fibrillation
Assistance Publique - Hôpitaux de Paris · NCT04932603
This study tests whether a team of different doctors can find the best blood-thinning treatments for older patients with atrial fibrillation to help them live longer and avoid serious health problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 820 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris (other) |
| Locations | 1 site (Paris) |
| Trial ID | NCT04932603 on ClinicalTrials.gov |
What this trial studies
This study focuses on the use of a multidisciplinary team to assess and prescribe antithrombotic therapy for older patients diagnosed with atrial fibrillation. The team, consisting of geriatricians, cardiologists, neurologists, and hematologists, evaluates the medical profiles of patients to suggest the most appropriate antithrombotic treatments. The primary goal is to measure the impact of this approach on all-cause mortality, ischemic events, and bleeding events over a period of three months, with secondary evaluations at six months. The study aims to address the high risk of adverse drug events in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are patients aged 75 years or older who have been diagnosed with atrial fibrillation and are hospitalized in participating geriatrics units.
Not a fit: Patients who oppose data collection for research purposes will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce adverse drug events and improve outcomes for older patients with atrial fibrillation.
How similar studies have performed: While the approach of using a multidisciplinary team is established in various healthcare settings, the specific application to antithrombotic therapy in older patients with atrial fibrillation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 75 years old patients or more * Diagnosis of AF * Hospitalized in one of the 6 geriatrics unit participating in the study and / or whose clinical file is reviewed by the multidisciplinary team Exclusion Criteria: * opposition to data collection for research purposes
Where this trial is running
Paris
- Unité de gériatrie aiguë, hôpital Pitié-Salpêtrière (Pr Marc Verny) — Paris, France (RECRUITING)
Study contacts
- Study coordinator: Lorène Zerah, MD, PhD
- Email: lorene.zerah@aphp.fr
- Phone: 01 42 16 03 36
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Atrial Fibrillation, Atrial fibrillation, Frail Elderly, Anticoagulants, Platelet Aggregation Inhibitors, Multidisciplinary team